Unsurprisingly, the IRS has announced an increase in the health flexible spending account (FSA) contribution limit for 2024 to $3,200, according to experts. This $150 boost provides employee the opportunity to set aside more tax-free money to pay for qualifying medical expenses.
What Does This Mean for Employers?
Companies will need to update plan rules for 2024 accordingly so employees can defer up to the new $3,200 cap.
In addition to the higher contribution ceiling, employers should note the carryover limit has also increased from $610 to $640. This means if an employer’s plan includes the carryover provision, employees can roll up to $640 of unused health FSA funds into 2025.
More Room for Healthcare Costs
The expanded contribution maximum gives employees more funds in their FSAs to pay for qualified medical expenses. This could be helpful since experts project healthcare price growth will remain high in 2024, potentially reaching up to 8.5 percent.
Later Than Usual Announcement
Open enrollment season is well under way, yet the IRS health FSA news is just rolling out. Experts point out the timing is behind schedule, considering HSA updates came in May and 401(k) changes were announced at the start of November.
For employers in mid-open enrolment who want to communicate plan specifics, it will be important to confirm FSA administrator data is up-to-date with 2024 guidance. Confirming contract details early can help avoid miscommunications around contribution room or carryovers.
What About HSAs and 401(k)s?
In addition to health FSA tweaks for 2024, contribution ceilings have also moved for other workplace savings vehicles like HSAs and 401(k)s. Here’s what else employers should know:
HSAs
- Self-only coverage contribution limit: $4,150
- Family coverage contribution limit: $8,300
401(k)s
- Employee contribution limit: $23,000
- Total contribution limit (with employer match): $69,000
For more employee benefits resources and industry insights, contact INSURICA today.
Copyright © 2024 Smarts Publishing. This is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel or an insurance professional for appropriate advice.
About the Author
Share This Story
Related Blogs
RxDC Reporting: What Employers Should Do Before the June 1 Deadline
Each year, group health plans must report detailed prescription drug and healthcare spending data to the Centers for Medicare & Medicaid Services (CMS). This reporting—commonly referred to as RxDC reporting—is due by June 1 and applies to most employer-sponsored group health plans that offer prescription drug coverage.
Chronic Condition Management 2.0: GLP-1 Alternatives and New Digital Therapeutics
Chronic conditions have long been the primary driver of employer healthcare spending, but 2026 marks a turning point in how organizations are approaching prevention, treatment, and long-term management. With GLP-1 medications dominating headlines — and budgets — employers are urgently exploring complementary or alternative strategies that can improve outcomes without unsustainable cost growth. The result is a new wave of digital therapeutics, metabolic health programs, and integrated care models that promise a more balanced approach to chronic disease management.
The Return-to-Office Reset: How Benefits Are Being Re-Engineered in 2026
After several years of experimentation, many employers are tightening hybrid schedules or requiring more in-office days. This “return-to-office reset” is reshaping benefits strategies as organizations look for ways to support commuting employees, improve onsite experience, and maintain flexibility. What began as a workplace policy shift is now driving a broader rethinking of how benefits can reinforce culture, productivity, and retention.